Melissa Fassbender, of OutSourcing-Pharma, published an article about a SubjectWell survey on Clinical Trial Awareness and Attitudes. For those surveyed: 50% are not aware of clinical trials and 57% could not recall any advertising for clinical trials. The lack of...
“Ethics, Quality and Human Safety in Clinical Trials: The Role of the IRB in Medical Device Studies” is the topic of an upcoming lecture by Gretchen Bowker, Pearl Pathways COO and Co-Founder, for Purdue University. The two-day event, April 8-9, is held at Roche and...
Ed Miseta of Clinical Leader, recently wrote an excellent article about FDA’s pilot Clinical Outcome Assessment (COA) Compendium and hit on some good points about what you need to know about it. The FDA defines a COA as a “measure of a patient’s symptoms, overall...
Bringing the Houston life science community together, BioHouston is sponsoring a chili competition, spirit, awards, and much more! This event is held on April 1st from 12pm – 4pm at the Bayou City Event Center, Houston TX. For an afternoon of fun and building the life...
Butler University is hosting a CEO Panel discussion moderated by Butler MBA Association President, Barry Dunham, on March 7th including Pearl Pathways’ own CEO and President, Diana Caldwell. Caldwell, with other industry experts, will share career reflections and...
